Involvement of the Endogenous Opioid System in the Drinking Behavior of Schizophrenic Patients Displaying Self-Induced Water Intoxication: A Double-Blind Controlled Study with Naloxone

Clinical Neuropharmacology

Volumn 19, Issue 3, 1996, Pages 252-258

  Nishikawa, Tadashi ^a,b   Tsuda, Akira ^a   Tanaka, Masatoshi ^a   Nishikawa, Mariko ^b   Koga, Itsuyuki ^b   Uchida, Yasunori ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Seiwakai Nishikawa Hospital   (Japan)

Author keywords

Endogenous opioid; Naloxone; Schizophrenia; Self induced water intoxication

Indexed keywords

NALOXONE; OPIATE; PLACEBO; SODIUM; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPONATREMIA; MALE; POLYDIPSIA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; WATER INTOXICATION; WEIGHT GAIN;

ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRINKING BEHAVIOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; SCHIZOPHRENIA; WATER INTOXICATION; WEIGHT GAIN;

EID: 0029968684     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619030-00007     Document Type: Article

References (22)

1. Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988;145:675-83.
2. Vieweg WVR, David JJ, Rowe WT, et al. Psychogenic polydipsia and water intoxication - concepts that have failed. Biol Psychiatry 1985;20:1308-20.
3. Vieweg WVR, Godleski LS, Pullian WR, et al. Development of water dysregulation during Arieti's third stage of schizophenia? Biol Psychiatry 1989;26:775-80.
4. Ukai M, Holtzman SG. Effects of intrahypothalamic administration of opioid peplides selective for μ-, κ-, and δ-receptors on different schedules of water intake in the rat. Brain Res 1988:495:275-81.
5. Ukai M, Nakayama S, Kameyama T. Inhibition of drinking by naltrexone in the rat: interaction with the dopamine D-1 antagonist SCH 23390 and D-2 antagonist sulpiride. Pharmacol Biochem Behav 1989;32:651-5.
6. Katafuchi T, Hattori Y, Nagatomo I, Koizumi K. κ-Opioid antagonist strongly attenuates drinking of genetically polydipsic mice. Brain Res 1991;546:1-7.
7. Nishikawa T, Tsuda A, Tanaka M, Nishikawa M, Koga I, Uchida Y. Naloxone attenuates drinking behavior in a schizophrenic patient displaying self-induced water intoxication. Clin Neuropharmacol 1992;15:310-4.
8. Nishikawa T, Tsuda A, Tanaka M, Nishikawa M, Koga I, Uchida Y. Naloxone attenuates drinking behavior in psychiatric patients displaying self-induced water intoxication. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:149-53.
9. Nishikawa T, Tsuda A, Tanaka M, Nishikawa M, Koga I, Uchida Y. Decreased polydipsia in schizophrenic patients treated with naloxone. Am J Psychiatry 1994;151:947.
10. Delva NJ, Crammer JL. Polydipsia in chronic psychiatric patients - body weight and plasma sodium. Br J Psychiatry 1988;152:242-5.
11. Vieweg WVR, David JJ, Rowe WT, Yank GR, Spradlin WW. Diurnal variation of urinary excretion for patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome). Biol Psychiatry 1986;21:1031-42.
12. Vieweg WVR, Godleski LS, Hundley PL, Tisdelle DA, Pruzinsky T, Yank GR. Diurnal weight gain as an index of polyuria and hyponatremia among chronically psychotic patients. Psychiatr Med 1988;6:23-8.
13. Vieweg WVR, Godleski LS, Pavalonis, DL, Hundley PL, Yank GR. Abnormal diurnal weight gain in chronic psychosis without seasonal change. Neuropsychobiology 1988;19:176-9.
14. Pickar D, Bunney WE Jr, Douillet P, et al. Repeated naloxone administration in schizophrenia: a phase II World Health Organization study. Biol Psychiatry 1989;25:440-8.
15. Davis GC, Bunney WE Jr, DeFraites EG, et al. Intravenous naloxone administration in schizophrenia and affective illness. Science 1977;197:74-7.
16. Bjørndal N, Casey DE, Gerlach J. Enkephalin, morphine, and naloxone in tardive dyskinesia. Psychopharmacology 1980;69:133-6.
17. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992;49:876-80.
18. Morley JE. Behavioral pharmacology for eating and drinking. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1267-71.
19. Dourish CT. Dopaminergic involvement in the control of drinking behavior: a brief review. Prog Neuropsychopharmacol Biol Psychiatry 1983;7:487-93.
20. Yoshida M, Yokoo H, Mizoguchi K, et al. Eating and drinking cause increased dopamine release in the nucleus accumbens and ventral tegmental area in the rat: measurement by in vivo microdialysis. Neurosci Lett 1992;139:73-6.
21. Li SJ, Sivam SP, McGinty JF, et al. Regulation of metabolism of striatal dynorphin by the dopaminergic system. J Pharmacol Exp Ther 1988;246:403-8.
22. Smith WO, Clark ML. Self-induced water intoxication in schizophrenic patients. Am J Psychiatry 1980;1055-9.